ATE180492T1 - Topischer fibrinogenkomplex - Google Patents

Topischer fibrinogenkomplex

Info

Publication number
ATE180492T1
ATE180492T1 AT92919794T AT92919794T ATE180492T1 AT E180492 T1 ATE180492 T1 AT E180492T1 AT 92919794 T AT92919794 T AT 92919794T AT 92919794 T AT92919794 T AT 92919794T AT E180492 T1 ATE180492 T1 AT E180492T1
Authority
AT
Austria
Prior art keywords
fibrinogen complex
topical fibrinogen
composition
topical
complex
Prior art date
Application number
AT92919794T
Other languages
English (en)
Inventor
Daphne C Tse
Samia S Mankarious
Shu Len Liu
William R Thomas
Melaine Alpern
Stanley T Enomoto
Cataline M Garanchon
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25037952&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE180492(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE180492T1 publication Critical patent/ATE180492T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92919794T 1991-09-05 1992-09-04 Topischer fibrinogenkomplex ATE180492T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75515691A 1991-09-05 1991-09-05

Publications (1)

Publication Number Publication Date
ATE180492T1 true ATE180492T1 (de) 1999-06-15

Family

ID=25037952

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92919794T ATE180492T1 (de) 1991-09-05 1992-09-04 Topischer fibrinogenkomplex

Country Status (8)

Country Link
EP (1) EP0602173B1 (de)
JP (2) JP2887329B2 (de)
AT (1) ATE180492T1 (de)
AU (1) AU675051B2 (de)
BR (1) BR1100978A (de)
CA (1) CA2117058A1 (de)
DE (1) DE69229272T2 (de)
WO (1) WO1993005067A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7229959B1 (en) 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
CA2162997A1 (en) * 1994-03-18 1995-09-28 Daphne C. Tse Topical fibrinogen complex
ATE184884T1 (de) * 1994-07-14 1999-10-15 Croix Rouge De Belgique Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
EP0804153B1 (de) * 1994-07-21 2003-10-01 Sirus Pharmaceuticals Ltd. Zusammensetzung enthaltend einen gewebeklebstoff und ein immobilisiertes therapeutisches wirkstoffteilchen
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5658588A (en) * 1995-03-31 1997-08-19 University Of Cincinnati Fibrinogen-coated liposomes
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
EP0869804A4 (de) * 1995-06-07 2001-08-16 American Nat Red Cross Supplementierte und nichtsupplementierte verdichtungsmittel, verfahren zu deren herstellung und verwendung
DE69734557T2 (de) * 1996-03-15 2006-07-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Sprühvorrichtung zum aufbringen von gewebeklebstoff
US6168788B1 (en) 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6780411B2 (en) * 1998-05-01 2004-08-24 Zymogenetics, Inc. Tissue sealant compositions
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
US20020155096A1 (en) 2001-02-23 2002-10-24 Chancellor Michael B. Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
JP4527901B2 (ja) * 2001-04-27 2010-08-18 シスメックス株式会社 フィブリノゲン測定用標準品および精度管理物質
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US20060155234A1 (en) 2002-09-10 2006-07-13 American National Red Cross Hemostatic dressing
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
CN100437279C (zh) * 2005-08-15 2008-11-26 友达光电股份有限公司 有源光罩除尘设备
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2009020612A1 (en) 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Methods and dressing for sealing internal injuries
EP2567692B1 (de) 2008-02-27 2016-04-06 Biomet Biologics, LLC Verwendung einer Vorrichtung zur Erzeugung Interleukin-1-rezeptorantagonistreicher Lösungen
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
CN109789162A (zh) 2016-09-01 2019-05-21 普拉斯富瑞有限公司 具有降低的纤溶活性的人类血液源产品及其在止血障碍中的用途
AU2018406738B2 (en) * 2018-01-31 2024-10-10 Rokit Healthcare Inc. Bioink composition for cartilage regeneration, method for manufacturing customized scaffold for cartilage regeneration using same, and customized scaffold for cartilage regeneration manufactured using manufacturing method
EP3934542B1 (de) 2019-03-06 2025-04-23 Gambro Lundia AB Vorrichtung und verfahren zur abgabe eines thrombinaktivierten fibrinversiegelers
JP2024529107A (ja) 2021-08-13 2024-08-01 ビオテスト・アクチエンゲゼルシャフト フィブリノゲン組成物および調製方法
EP4387993A1 (de) 2021-08-18 2024-06-26 Biotest AG Trockene wärmebehandlung von faktor viii aus plasma

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132687B2 (de) * 1972-06-15 1976-09-14
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
WO1993005822A1 (en) * 1991-09-27 1993-04-01 Octapharma Ag Tissue glue prepared by using cryoprecipitate
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.

Also Published As

Publication number Publication date
CA2117058A1 (en) 1993-03-18
JPH1121249A (ja) 1999-01-26
EP0602173A4 (de) 1995-03-01
JP2887329B2 (ja) 1999-04-26
EP0602173A1 (de) 1994-06-22
AU675051B2 (en) 1997-01-23
AU2577992A (en) 1993-04-05
BR1100978A (pt) 2000-04-11
DE69229272D1 (de) 1999-07-01
JPH07501517A (ja) 1995-02-16
WO1993005067A1 (en) 1993-03-18
DE69229272T2 (de) 2000-02-03
EP0602173B1 (de) 1999-05-26

Similar Documents

Publication Publication Date Title
ATE180492T1 (de) Topischer fibrinogenkomplex
ATE111360T1 (de) Chirurgisches klebstoffmaterial.
PT96103A (pt) Processo para a preparacao de proteinas fibrinoliticas e anti-tromboticas activaveis
NO933624L (no) Fibrin-tettingsmiddelblandinger og fremgangsmåter for anvendelse
DK0541507T3 (da) Thrombin samt fremgangsmåde til dets fremstilling
DK0691858T3 (da) Tokomponent fibrinklæber
FI953916A0 (fi) Fibrinogeenireseptoriantagonisteja
ATE146525T1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
NO931224L (no) Fremgangsmaate for spalting av proteiner
FI932196A0 (fi) Foerfarande foer bestaemning av fibrinogen
ATE151295T1 (de) Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung
DK0556906T3 (da) Kalibrator og dens anvendelse til en immunanalyse
DK0994187T3 (da) Renin-aktivt stof omfattende humant prorenin og antistoffer mod prorenin-profragmentet
FI932194A0 (fi) Anvaendningen av protrombinfragment
ATE252917T1 (de) Verwendung von fibrinogen-multimeren in fibrinklebern
DK205188A (da) Proteinprotease-inhibitorer af streptomyces
DE69637278D1 (de) Methode zur herstellung von thrombin
DE3464599D1 (de) Alpha-allenic-alpha-amino acids
FI953849L (fi) Menetelmä vampyyrilepakon syljen plasminogeeniaktivaattoreiden valmistamiseksi